CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $31,968,735
- in 3 filings, $32.0M under 10b5-1 plans
Net −$31,968,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-24 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −190 | $158.65 | $30K | 9,402 |
| 2026-04-24 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −375 | $159.46 | $60K | 9,027 |
| 2026-04-24 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −330 | $160.40 | $53K | 8,697 |
| 2026-04-24 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −28 | $161.22 | $5K | 8,669 |
| 2026-04-24 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −3 | $162.53 | $488 | 8,666 |
| 2026-04-23 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −267 | $164.47 | $44K | 10,399 |
| 2026-04-23 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −158 | $165.38 | $26K | 10,241 |
| 2026-04-23 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −127 | $166.56 | $21K | 10,114 |
| 2026-04-23 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −373 | $167.37 | $62K | 9,741 |
| 2026-04-23 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −54 | $168.43 | $9K | 9,687 |
| 2026-04-23 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −21 | $169.56 | $4K | 9,666 |
| 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −31 | $165.70 | $5K | 11,635 |
| 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −20 | $166.32 | $3K | 11,615 |
| 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −141 | $167.42 | $24K | 11,474 |
| 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −101 | $168.64 | $17K | 11,373 |
| 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −105 | $169.52 | $18K | 11,268 |
| 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −75 | $170.58 | $13K | 11,193 |
| 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −257 | $171.62 | $44K | 10,936 |
| 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −249 | $172.49 | $43K | 10,687 |
| 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −21 | $173.04 | $4K | 10,666 |
Page 7 of 10 · 186 trades